Key result
Percutaneous closure of residual shunting in a fenestrated atrial septal defect occluder using a second 8-mm device was successful, with no thromboembolism or infection observed over 12 months.
Why the study?
Is percutaneous closure of residual shunting in a fenestrated ASD occluder feasible and safe?
Case Report (n=1)
No
Is percutaneous closure of residual shunting in a fenestrated ASD occluder feasible and safe?
Percutaneous closure of residual shunting in a fenestrated ASD occluder appears feasible and safe, offering a potential strategy to reduce paradoxical embolism risk.
May offer a minimally invasive option for residual fenestrated ASD shunts; leaves open questions on long-term safety and broader use.
RATIONALE: Fenestrated atrial septal defect (ASD) occlusion has been performed in patients complicated with severe pulmonary hypertension (PH). Nevertheless, the persistent interatrial residual shunting in the fenestration might increase the risk of paradoxical embolism. Percutaneous closure of fenestrated ASD occluder (ASO) has not yet been reported. PATIENT CONCERNS: A 26-year-old patient with a 25-mm ASD and severe PH underwent ASD closure using a Memory ASO with a waist of 32 and 6-mm custom-made fenestration. Echocardiography revealed the fenestration remained 6 mm and the pulmonary artery pressure decreased to the normal range at the 6-month follow-up. DIAGNOSES: Persistent interatrial residual shunting in ASO. INTERVENTIONS: Percutaneous closure of residual interatrial shunting was performed using a waist of 8-mm ASO under guidance of TEE. OUTCOMES: The fenestration was successfully closed. Neither thromboembolism nor infection events were noted during the 12-month follow-up after the procedure. LESSONS: This case illustrates that percutaneous closure of the residual shunting in fenestrated ASO was feasible and safe for short- and long-term.
No takes yet. Share an insight, caveat, or question.
Man et al. (2018) conducted a case report in Atrial septal defect with severe pulmonary hypertension and residual shunting in fenestrated occluder (n=1). Percutaneous closure of residual shunting using an 8-mm ASO was evaluated on Successful closure of fenestration and occurrence of thromboembolism or infection. Percutaneous closure of residual shunting in a fenestrated atrial septal defect occluder using a second 8-mm device was successful, with no thromboembolism or infection observed over 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: